First Midwest Bank Trust Division’s Amicus Therapeutics FOLD Stock Holding History

First Midwest Bank Trust Division’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-10,000	Closed	-$80K	–	363
2019 Q3	$80K	Sell	10,000 -1,900	-16%	-$20.6K	0.01%	364
2019 Q2	$149K	Sell	11,900 -18,000	-60%	-$228K	0.02%	370
2019 Q1	$407K	Sell	29,900 -88,824	-75%	-$1.09M	0.06%	291
2018 Q4	$1.14M	Buy	+118,724	New	+$1.31M	0.17%	145
2018 Q2	–	Sell	-35,229	Closed	-$530K	–	423
2018 Q1	$530K	Sell	35,229 -31,961	-48%	-$486K	0.07%	263
2017 Q4	$967K	Sell	67,190 -1,378	-2%	-$18.9K	0.12%	212
2017 Q3	$1.03M	Buy	+68,568	New	+$907K	0.13%	208

Other funds holding FOLD

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

First Midwest Bank Trust Division's FOLD Position: Q4 2019 in Review

First Midwest Bank Trust Division sold out of Amicus Therapeutics (FOLD) in Q4 2019, closing a stake of 10,000 shares — an estimated $80K sold.

First Midwest Bank Trust Division first reported a position in FOLD in Q3 2017 and held it in 7 quarters. The position peaked at $1.14M in Q4 2018. 224 funds tracked by Wall St. Rank hold FOLD as of Q4 2019.

First Midwest Bank Trust Division reported no remaining Amicus Therapeutics position as of Q4 2019 after selling out during the quarter.
First Midwest Bank Trust Division sold 10,000 Amicus Therapeutics shares in Q4 2019, an estimated $80K.
First Midwest Bank Trust Division first reported a position in Amicus Therapeutics in Q3 2017 and held it in 7 quarters.
First Midwest Bank Trust Division's Amicus Therapeutics position peaked at $1.14M in Q4 2018.
224 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q4 2019.

Based on First Midwest Bank Trust Division's 13F filing for Q4 2019, filed 23 Jan 2020.